doi: 10.3390/brainsci13111503/ Retrieved from Baranwal, N., Yu, P
It decreased CMRglu in the hypothalamus, along with reduced plasma insulin levels (Daniele et al., Plasma GLP-1 levels showed a positive correlation with regional cerebral blood flow (rCBF) in the left dorsolateral prefrontal cortex (dlPFC) and hypothalamus independent of sex, age, adiposity, insulin, glucose, and free fatty acids (Pannacciulli et al., Combined infusion of GLP-1 and PYY in fasted subjects reduced energy intake and decreased brain activity in the amygdala, caudate, insula, NAc, OFC, and putamen to food vs
At $249 to $297 per month through Direct Meds, long-term use costs $3,000 to $3,600 per year
These products are not meant to diagnose treat or cure any disease or medical condition
What the Review Covers This PM&R-centered narrative review synthesizes evidence on medical cannabis for non-pain indications: spasticity, neurologic and seizure disorders, sleep disturbances, and chemotherapy-induced nausea and vomiting